People are overdosing on off-brand weight-loss drugs, FDA warns
The FDA has approved injectable versions of semaglutide for weight-loss and diabetes, cautioning against dangerous imitations due to pricing and supply issues. [ more ]
People are overdosing on off-brand weight-loss drugs, FDA warns
The FDA has approved injectable versions of semaglutide for weight-loss and diabetes, cautioning against dangerous imitations due to pricing and supply issues. [ more ]
More People Are Overdosing on Ozempic Alternatives
Patients are experiencing serious risks by overdosing on compounded GLP-1 medications, spurred by demand for cheaper alternatives and availability issues of brand-name products. [ more ]